Rubicon Organics Inc

Healthcare CA ROMJ

0.48CAD
-0.01(2.04%)

Last update at 2026-03-10T19:59:00Z

Day Range

0.480.49
LowHigh

52 Week Range

0.360.73
LowHigh

Fundamentals

  • Previous Close 0.49
  • Market Cap36.27M
  • Volume15702
  • P/E Ratio54.00
  • Dividend Yield-%
  • EBITDA4.47M
  • Revenue TTM55.06M
  • Revenue Per Share TTM0.92
  • Gross Profit TTM 19.12M
  • Diluted EPS TTM0.01

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Income before tax -2.56241M -1.82354M -3.85585M -14.52074M -14.34954M
Minority interest - - - - -
Net income -2.56241M -1.82354M -3.85585M -14.52074M -14.98317M
Selling general administrative 16.37M 13.93M 16.07M 14.58M 12.13M
Selling and marketing expenses - - - - -
Gross profit 15.42M 13.14M 13.81M 1.51M -0.66396M
Reconciled depreciation 3.27M 3.12M 3.05M 2.40M 1.72M
Ebit - - - -13.07964M -12.91974M
Ebitda - - 0.22M -10.86915M -10.37370M
Depreciation and amortization - - - - -
Non operating income net other - - - - -
Operating income -1.16988M -1.08344M -2.58868M -13.34100M -11.98987M
Other operating expenses - - - - 0.93M
Interest expense 1.15M 1.10M 1.02M 1.26M 2.26M
Tax provision - - - - 0.00000M
Interest income - - - 0.08M -
Net interest income -1.14958M -1.10126M -1.02276M -1.17151M -2.25819M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense - - - - -
Total revenue 48.70M 40.12M 35.52M 22.61M 9.39M
Total operating expenses 49.87M 41.20M 38.11M 35.95M 21.38M
Cost of revenue 33.28M 26.98M 21.71M 21.10M 10.05M
Total other income expense net -0.24295M 0.36M -0.24441M -0.00823M -0.10148M
Discontinued operations - - - - -0.63363M
Net income from continuing ops -2.56241M -1.82354M -3.85585M -14.52074M -14.34954M
Net income applicable to common shares - - - -14.52074M -14.98317M
Preferred stock and other adjustments - - - - -
Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Total assets 56.61M 54.89M 56.11M 54.84M 51.07M
Intangible assets 2.38M 2.38M 2.38M 1.88M 1.88M
Earning assets - - - - -
Other current assets - - - 0.15M 0.45M
Total liab 19.21M 17.00M 17.77M 15.94M 22.23M
Total stockholder equity 37.40M 37.89M 38.33M 38.90M 28.84M
Deferred long term liab - - - - -
Other current liab - - - - 0.47M
Common stock - - - 107.21M 86.35M
Capital stock 108.30M 107.79M 107.61M 107.21M 86.35M
Retained earnings -94.08551M -91.52311M -89.69957M -85.84373M -71.32299M
Other liab - - - - -
Good will - - - - -
Other assets - - - 0.48M 0.50M
Cash 9.86M 9.78M 8.29M 11.58M 12.14M
Cash and equivalents - - - - -
Total current liabilities 10.71M 16.91M 8.37M 6.94M 22.01M
Current deferred revenue - - - - -
Net debt - 0.48M 1.87M - 1.50M
Short term debt - - - - -
Short long term debt 1.32M 10.26M 0.76M 0.66M 13.64M
Short long term debt total - - - - -
Other stockholder equity - - - 17.54M 13.82M
Property plant equipment - - - 25.30M 22.51M
Total current assets 30.65M 27.04M 27.69M 27.17M 26.18M
Long term investments - - - - -
Net tangible assets - - - 37.02M 26.96M
Short term investments - - - - -
Net receivables 5.62M 3.32M 4.77M 4.16M 2.27M
Long term debt 8.48M - 9.40M 8.95M -
Inventory 12.57M 11.28M 12.66M 10.61M 10.14M
Accounts payable 1.78M 1.15M 0.68M 1.57M 1.75M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - - - - -
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other - - - - -
Deferred long term asset charges - - - - -
Non current assets total 25.96M 27.85M 28.41M 27.67M 24.90M
Capital lease obligations 0.09M 0.14M 0.06M 0.21M 0.34M
Long term debt total - - - - -
Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Investments -1.54547M -3.38268M -4.45086M -5.49732M 3.08M
Change to liabilities - - - -0.39168M 2.06M
Total cashflows from investing activities - - - -5.49732M 3.08M
Net borrowings -1.47437M -0.10700M - -4.19169M -0.13036M
Total cash from financing activities -1.77409M -0.82934M -0.83856M 15.30M 21.26M
Change to operating activities - - - 0.57M -0.22435M
Net income -2.56241M -1.82354M -3.85585M -14.52074M -14.98317M
Change in cash 0.07M 2.56M -3.28933M -0.55302M 10.05M
Begin period cash flow 9.78M 6.84M 11.58M 12.14M 2.08M
End period cash flow 9.86M 9.42M 8.29M 11.58M 12.14M
Total cash from operating activities 3.40M 6.79M 1.95M -10.44234M -14.31085M
Issuance of capital stock - - 0.00000M 21.22M 13.31M
Depreciation 3.27M 3.12M 3.05M 2.40M 1.72M
Other cashflows from investing activities - - - - -
Dividends paid 0.00000M 0.00000M 0.00000M 0.00000M 0.00000M
Change to inventory -1.21325M 0.67M -0.44611M -1.13311M -2.46130M
Change to account receivables -2.49167M 0.86M -0.62562M -1.58647M -2.36433M
Sale purchase of stock - - - - -
Other cashflows from financing activities - - - -2.33118M -0.89602M
Change to netincome - - - 4.22M 1.95M
Capital expenditures 1.55M 3.38M 4.45M 5.50M 5.98M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital -0.57776M 2.33M 0.08M -2.53648M -2.99114M
Stock based compensation 2.07M 1.76M 3.04M 2.14M 2.55M
Other non cash items 1.03M 6.69M 0.89M 2.05M -8.51824M
Free cash flow 1.85M 3.41M -2.49886M -15.93966M -20.29518M

Peer Comparison

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Company Change (CAD) Price (CAD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
ROMJ
Rubicon Organics Inc
-0.01 2.04% 0.48 54.00 49.51 0.52 0.65 0.57 4.46
RX
Biosyent Inc.
-0.06 0.39% 15.50 16.87 14.43 3.74 3.54 2.82 9.35
LSL
LSL Pharma Group Inc.
-0.01 2.41% 0.41 25.50 - 2.31 2.48 3.41 12.21
DB
Decibel Cannabis Company Inc
0.005 4.00% 0.13 3.17 5.43 0.50 0.86 0.86 4.57
ZYUS
ZYUS Life Sciences Corporation
- -% 0.60 - - 111.93 4.41 145.46 -4.258

Reports Covered

Stock Research & News

Profile

Rubicon Organics Inc., together with its subsidiaries, engages in the production, processing, and sale of organic cannabis for the recreational and medical-use markets in Canada and internationally. The company offers cannabis products in jar, bag, pre-rolls, edible, poutine sauce mix, milled flower, soft gels, hash, blunt, gummies, flower variety pack, pot brownies, resin vape, relief stick, cool stick, and oil formats. It sells its products under the Simply Bare Organic, 1964 Supply Co, Homestead Cannabis Supply, LAB THEORY, and Wildflower brand names. The company was formerly known as West Coast Land Corporation and changed its name to Rubicon Organics Inc. in May 2018. Rubicon Organics Inc. was incorporated in 2015 and is headquartered in Vancouver, Canada.

Rubicon Organics Inc

744 West Hastings Street, Vancouver, BC, Canada, V6C 1A5

Key Executives

Name Title Year Born
Mr. Jesse McConnell M.A. Co-Founder, CEO & Director 1977
Ms. Margaret Ruth Brodie C.A., CPA CFO & Director 1978
Mr. Peter Dierx VP of Operations NA
Mr. Benoit Pinsonneault VP of Sales NA
Ms. Monika Mascitti VP of People NA
Ms. Melanie Ramsey Chief Commercial Officer & Director NA
Ms. Margaret Ruth Brodie C.A., CPA CEO & Director 1979
Ms. Melanie Ramsey Chief Commercial Officer NA
Ms. Janis Risbin CFO & Company Secretary NA
Mr. Tyler Perkins Director of Operations & Facilities NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.